Press release
Exploring the Expanding Intravenous Immunoglobulin (IVIG) Market: Understanding the Growing Demand for Immunoglobulin Therapy in Treating Autoimmune and Neurological Disorders
๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ข๐ง๐ญ๐ซ๐๐ฏ๐๐ง๐จ๐ฎ๐ฌ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐๐๐จ๐ฎ๐ง๐ญ๐๐ ๐๐จ๐ซ $๐,๐๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐, ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐๐๐ก $๐๐,๐๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ซ๐๐ ๐ข๐ฌ๐ญ๐๐ซ๐ข๐ง๐ ๐ ๐๐๐๐ ๐จ๐ ๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/request-sample/325
The global IVIG market is driven by factors such as high prevalence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP) and hypogammaglobulinemia coupled with surge in geriatric population and rise in the number of hemophilic patients. In addition, increase in production of immunoglobulin with better plasma quality using advanced purification techniques is expected to supplement the market growth. On the other hand, technological advancements in IVIG products are anticipated to provide lucrative opportunities in the market in near future. However, stringent government regulations towards IVIG products and side effects associated with the use of IVIG impede the growth of the market.
When someone receives IVIG, the immunoglobulins are given through a vein in the arm and are infused into the bloodstream. Once in the bloodstream, the immunoglobulins work to boost the immune system's ability to fight off infections and diseases by providing additional antibodies to the body.
IVIG is often used as a treatment option when other medications have not been effective, and it can help reduce the severity and duration of certain illnesses. The medication is generally considered safe, but like any medication, there can be side effects. It is important to discuss the potential benefits and risks with a healthcare provider before starting treatment.
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐ฌ ๐ฐ๐ก๐๐ซ๐ ๐๐๐๐ ๐ข๐ฌ ๐ฎ๐ฌ๐๐ ๐ข๐ง๐๐ฅ๐ฎ๐๐:
Autoimmune diseases: IVIG is used to treat autoimmune diseases such as lupus, rheumatoid arthritis, and multiple sclerosis.
Immunodeficiencies: IVIG is used to treat primary immunodeficiency disorders (PIDs) and secondary immunodeficiencies, which can occur as a result of certain medical treatments, such as chemotherapy.
Neurological disorders: IVIG is used to treat neurological disorders such as Guillain-Barrรฉ syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis.
Blood disorders: IVIG is used to treat blood disorders such as idiopathic thrombocytopenic purpura (ITP) and Kawasaki disease.
Infectious diseases: IVIG is used to treat certain infectious diseases such as HIV and hepatitis B.
The specific segment of IVIG use depends on the patient's medical condition and the doctor's recommendation.
๐๐ฌ๐ค ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฑ๐ฉ๐๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/325
๐๐ก๐ ๐ญ๐จ๐ฉ ๐๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ง๐ญ๐ซ๐๐ฏ๐๐ง๐จ๐ฎ๐ฌ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง (๐๐๐๐) ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ซ๐:
Grifols
CSL Behring
Takeda Pharmaceutical Company Limited
Octapharma AG
Kedrion Biopharma Inc.
Biotest AG
Shire Plc
China Biologic Products Holdings, Inc.
LFB S.A.
ADMA Biologics, Inc.
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ (๐๐จ๐จ๐ค ๐๐จ๐ฐ ๐ฐ๐ข๐ญ๐ก ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ):
RNA Based Therapeutic Market https://www.alliedmarketresearch.com/rna-based-therapeutics-market
Epigenetics Market https://www.alliedmarketresearch.com/epigenetics-market
Exosome Diagnostic and Therapeutic Market https://www.alliedmarketresearch.com/exosome-diagnostic-and-therapeutic-market
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exploring the Expanding Intravenous Immunoglobulin (IVIG) Market: Understanding the Growing Demand for Immunoglobulin Therapy in Treating Autoimmune and Neurological Disorders here
News-ID: 3018550 • Views: โฆ
More Releases from Allied Market Research
Transdermal Drug Delivery Systems Market: Growing Preference for Transdermal Dru โฆ
Surge in population across the world has given way to a steep increase in demand for geriatric medications and treatments. At the same time, the number of patient pool suffering from chronic syndromes such as arthritis, heart ailments, and diabetes has also amplified to a significant extent. These factors have escalated the adoption of transdermal drug delivery systems in more than one way.
According to Allied Market Research, theโฆ
Pharmacy Automation System Market: Exploring Its Lucrative Opportunities and Com โฆ
The global pharmacy automation system industry report provides a comprehensive analysis of market size, share, and growth rates across various segments at both national and regional levels. It delves into the dynamics of the industry, highlighting emerging trends, key growth drivers, opportunities, and potential constraints. This analysis offers valuable insights into the current landscape and future prospects of the market. Additionally, the report presents significant qualitative findings that shed lightโฆ
Arthroscopy Devices Market is projected to reach $41.9 billion by 2030 | Arthrex โฆ
The Arthroscopy Devices Market is a robust, growing sector driven by rising sports injuries, aging populations, and demand for minimally invasive surgery (MIS), encompassing tools like arthroscopes, visualization systems, implants, and shavers for knee, shoulder, hip surgeries, with key players including Arthrex, Stryker, and Johnson & Johnson, and experiencing strong growth in Asia-Pacific, while facing challenges like high costs but benefiting from innovations in robotics and imaging.
As per theโฆ
Plywood Market Poised for Strong Growth, Expected to Reach $100.2 Billion by 203 โฆ
Allied Market Research published a report titled, Plywood Market Size, Share, Competitive Landscape and Trend Analysis Report by Type (Hardwood, Softwood, Others), Application (Construction, Industrial, Furniture, Others), and End User (Residential, Non-Residential): Global Opportunity Analysis and Industry Forecast, 2023-2032. According to the report, the global plywood market was valued at $55,663.5 million in 2022, and is projected to reach $100,155.6 million by 2032, registering a CAGR of 6.1% from 2023โฆ
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trendsโฆ
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,โฆ
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise โฆ
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary researchโฆ
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are โฆ
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support marketโs growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across theโฆ
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term โimmunoglobulinโ refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted fromโฆ
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog โฆ
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the companyโs strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course ofโฆ
